Capreomycin is an FDA-approved antibiotic used to treat multidrug-resistant tuberculosis (MDR-TB). It targets and inhibits the growth of Mycobacterium tuberculosis, the bacteria responsible for tuberculosis. Capreomycin is particularly effective against TB strains resistant to other first-line drugs. It is often used in combination with other anti-TB medications to enhance treatment outcomes.
CAT# | R2018 |
CAS | 11003-38-6 |
* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
Studies on the binding affinities of darifenacin hydrobromide and human muscarinic receptor subtypes show strong ...
Ramoplanin is a new kind of glycopeptide antibiotics, which can inhibit the biosynthesis of the cell walls of gr ...
With the advancement of technology and the increasing demand for skin care, the variety of ingredients in the skin care marke ...
DAMME (DA) is a guanine, often referred to as FK 33-824 (FK), which is a long-acting enkephalin analog. Natur ...
The endocytosis of AMPA receptors (AMPARs) requires the GTPase activity of dynamin. Since it is now established ...